Business profile

EpiMedical Oy

EpiMedical Oy's registered office is Hämeenlinna. It is a limited company. The company was established on 2023-08-22. It operates in the industry of medical specialists activities. In its latest retained statement for 2025-12-31, revenue was €163,754 and operating profit was €125,410.

Business ID 3382202-7ValidUnclaimed company profile

Trusted core data

Public company details from the trade register.

Business ID
3382202-7
Sector
Medical specialists activities
Municipality
Hämeenlinna
Company form
Limited company
Registration date
2023-08-22
Business ID registration date
2023-08-09
Business status
Valid
Profile ownership
Unclaimed company profile

Contact and location summary

Visiting address: Talaskuja 3, 13200, Hämeenlinna

About EpiMedical Oy

Financial position and key figures for the company.

EpiMedical Oy's location municipality is Hämeenlinna. It is a limited company. The company was established on 2023-08-22. It operates in the industry of medical specialists activities. In its latest retained statement for 2025-12-31, revenue was €163,754 and operating profit was €125,410. The latest retained financial statement for 2025-12-31 shows revenue of €163,754 and profit for the financial year of €100,379. Based on the latest retained statement, revenue growth was +4.1%, operating margin was +76.6%, and equity ratio was +94.6%.

Financial highlights

Key figures from the latest financial period.

Open full statement
Latest financial period

2025-12-31

Imported periods1
PRH parsed1
Profile sourcePRH/XBRL financial statement
Derived indicators
Revenue growth4.1%
Operating margin76.6%
Equity ratio94.6%
Balance-sheet contextLatest financial period
Other operating income€4Previous: €0
Cash and bank€66,050Previous: €29,241
Retained earnings€87,601Previous: €0
Equity€187,980Previous: €95,219
Liabilities€10,813Previous: €9,996
Current assets€83,270Previous: €45,199
Current liabilities€10,813Previous: €9,996

Financial ratios

Financial ratios based on financial statement data. Source: PRH/XBRL-tilinpäätös.

Equity ratioGood
100/100 · Improving
94.6 %2024-12-31: 90.5 %
Current ratioGood
100/100 · Improving
6.11x2024-12-31: 2.93x
Operating profit marginGood
100/100 · Improving
76.6 %2024-12-31: 75.1 %

Registry status and identifiers

Current registry information and identifiers based on YTJ data.

YTJ statusValid
Trade RegisterRegistered
Business ID3382202-7
EU IDFIFPRO.3382202-7
MunicipalityHämeenlinna
Current registered entries
2023-08-09Registered in Tax Administration (Prepayment Register)
2023-08-22Registered in Tax Administration (Tax Administration)
2023-08-22Registered in Patent and Registration Office (Trade Register)

Risk certificate

An open-data based company stability and risk signal.

BUSINESS.fi

BUSINESS.fi Luottoluokitus

Profile-specific risk signal based on open data

Automatic gradeNot a credit decision
A2
Very goodEpiMedical Oy
Grade upgradedB1 → A2 · new analysis 2026-09-17
Model score83/100
Assessment confidenceMedium
Evidence qualityUsable financial evidenceFinancial data included
Peer comparisonSame industryDescriptive comparison – does not change the model score.
68 peers
Solvency66%
Better than 66% of peers
Profitability97%
Better than 97% of peers
Liquidity87%
Better than 87% of peers
Financial statement reporting patternLimited evidenceBased on observed PRH financial period end and registration dates. This descriptive evidence does not change the v0.14 score.
1 observed filings
Latest registration lag41 days after period end
Typical registration lag41 days after period end
Annual continuity1 consecutive periods
Supporting factors
  • Strong equity ratio
  • Strong operating profitability
  • Healthy short-term liquidity
Risk factors to note

No material separate warning signals.

Rating historyAutomatic assessment developmentChanges are derived from evidence differences between persisted automatic assessments.
5 assessments
A2
2026-09-17 22:0783/100 · v0.14
B1 → A2 · +23 points
  • Evidence strengthened: a PRH/XBRL financial statement was added to the assessment (2025-12-31).
  • Evidence quality: Registry and statistical evidence → Usable financial evidence.
B1
2026-09-1460/100 · v0.14
B1 → B1
B1
2026-09-1460/100 · v0.13
B2 → B1 · +1 points
  • Assessment confidence: Low → Medium.
  • Evidence quality: Registry and statistical evidence → Registry and statistical evidence.
  • New risk factor: Sufficient structured financial metrics are not available.
B2
2026-09-1359/100 · v0.12
Oldest retained automatic assessment in this comparison
Automatic model gradeA2
Automatic model snapshot2026-09-17
Automatic model versionopen-risk-grade-v0.14
Financial data included

The grade can use open digital financial statement data together with registry signals.

Verify assessment

Risk context

When sufficient source-backed financial metrics are not available for a Tier 1 assessment, BUSINESS.fi shows registry, industry, and regional context.

Industry riskvery low
94/100

Industry context is very low based on normalized open statistical inputs.

Age and continuityNuori
35/100

The company has about 3 years of registry continuity.

Registry and status signalsRajallinen
39/100

Registry history, filing recency, and active register markings are still limited or mixed.

Events & news

Verified events and sourced external company news in one timeline.

Risk grade updatedRisk gradeEvidence verified
17 Sept 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade B1 → A2.
Risk grade updatedRisk gradeEvidence verified
14 Sept 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade B1.

Registry timeline

Trade register notifications shown on a timeline.

4 register eventsLatest event: 2026-02-10

Financial statements availability

Available financial statement periods and PRH source filings.

1 financial statement periodsLatest financial period: 2025-12-31

Profile source and ownership

Profile based on public registry data
BUSINESS.fi has created this profile from public company information. Source data updated 2025-12-31.

This company profile has not been claimed yet

EpiMedical Oy shows public core facts. A company representative can claim the profile, update public information, and access owner tools.